These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 23526138
1. Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT. Cheng C, Heiss C, Dimitrakopoulou-Strauss A, Govindarajan P, Schlewitz G, Pan L, Schnettler R, Weber K, Strauss LG. Am J Nucl Med Mol Imaging; 2013; 3(2):118-28. PubMed ID: 23526138 [Abstract] [Full Text] [Related]
3. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics. Sachpekidis C, Goldschmidt H, Hose D, Pan L, Cheng C, Kopka K, Haberkorn U, Dimitrakopoulou-Strauss A. Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650 [Abstract] [Full Text] [Related]
4. Application of F-18-sodium fluoride (NaF) dynamic PET-CT (dPET-CT) for defect healing: a comparison of biomaterials in an experimental osteoporotic rat model. Cheng C, Alt V, Pan L, Thormann U, Schnettler R, Strauss LG, Heinemann S, Schumacher M, Gelinsky M, Nies B, Dimitrakopoulou-Strauss A. Med Sci Monit; 2014 Oct 15; 20():1942-9. PubMed ID: 25317537 [Abstract] [Full Text] [Related]
8. Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation. Sachpekidis C, Hillengass J, Goldschmidt H, Wagner B, Haberkorn U, Kopka K, Dimitrakopoulou-Strauss A. Eur J Nucl Med Mol Imaging; 2017 Jan 15; 44(1):50-62. PubMed ID: 27573638 [Abstract] [Full Text] [Related]
9. Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis. Okazumi S, Dimitrakopoulou-Strauss A, Schwarzbach MH, Strauss LG. Hell J Nucl Med; 2009 Jan 15; 12(3):223-8. PubMed ID: 19936332 [Abstract] [Full Text] [Related]
10. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study. Uchida K, Nakajima H, Miyazaki T, Yayama T, Kawahara H, Kobayashi S, Tsuchida T, Okazawa H, Fujibayashi Y, Baba H. J Nucl Med; 2009 Nov 15; 50(11):1808-14. PubMed ID: 19837766 [Abstract] [Full Text] [Related]
11. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis. Frost ML, Fogelman I, Blake GM, Marsden PK, Cook G. J Bone Miner Res; 2004 Nov 15; 19(11):1797-804. PubMed ID: 15476579 [Abstract] [Full Text] [Related]
19. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection? Strauss LG, Klippel S, Pan L, Schönleben K, Haberkorn U, Dimitrakopoulou-Strauss A. Eur J Nucl Med Mol Imaging; 2007 Jun 15; 34(6):868-77. PubMed ID: 17219134 [Abstract] [Full Text] [Related]
20. Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET. Dimitrakopoulou-Strauss A, Hoffmann M, Bergner R, Uppenkamp M, Haberkorn U, Strauss LG. Clin Nucl Med; 2009 Sep 15; 34(9):576-84. PubMed ID: 19692817 [Abstract] [Full Text] [Related] Page: [Next] [New Search]